119 related articles for article (PubMed ID: 38302173)
1. Polyautoimmunity in Patients With Anticyclic Citrullinated Peptide Antibody-Positive and -Negative Rheumatoid Arthritis: a Nationwide Cohort Study From Denmark.
Kristensen S; Hagelskjær AM; Cordtz R; Bliddal S; Mortensen AS; Nielsen CH; Feldt-Rasmussen U; Lauridsen KB; Dreyer L
J Rheumatol; 2024 Apr; 51(4):350-359. PubMed ID: 38302173
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of treatment patterns and healthcare utilization of newly-diagnosed rheumatoid arthritis patients by anti-cyclic citrullinated peptide antibody status.
Lamerato L; Price K; Szymialis R; Eaddy M; Ogbonnaya A; Shih HC; Ahmad H
J Med Econ; 2018 Mar; 21(3):231-240. PubMed ID: 29027497
[TBL] [Abstract][Full Text] [Related]
3. Impact of Cyclic Citrullinated Peptide Antibody Level on Progression to Rheumatoid Arthritis in Clinically Tested Cyclic Citrullinated Peptide Antibody-Positive Patients Without Rheumatoid Arthritis.
Ford JA; Liu X; Marshall AA; Zaccardelli A; Prado MG; Wiyarand C; Lu B; Karlson EW; Schur PH; Deane KD; Sparks JA
Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1583-1592. PubMed ID: 30570827
[TBL] [Abstract][Full Text] [Related]
4. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
5. Effects of Aging on Rheumatoid Factor and Anticyclic Citrullinated Peptide Antibody Positivity in Patients With Rheumatoid Arthritis.
Takanashi S; Takeuchi T; Kaneko Y
J Rheumatol; 2023 Mar; 50(3):330-334. PubMed ID: 36319009
[TBL] [Abstract][Full Text] [Related]
6. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
[TBL] [Abstract][Full Text] [Related]
7. Economic Evaluation of Anticyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis.
An J; Bider-Canfield Z; Kang J; Alemao E; Connolly SE; Lin AT; Cheetham TC
J Manag Care Spec Pharm; 2019 Apr; 25(4):469-477. PubMed ID: 30917075
[TBL] [Abstract][Full Text] [Related]
8. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.
Heidari B; Firouzjahi A; Heidari P; Hajian K
Ann Saudi Med; 2009; 29(6):467-70. PubMed ID: 19847085
[TBL] [Abstract][Full Text] [Related]
10. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
[TBL] [Abstract][Full Text] [Related]
11. Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.
Gossec L; Paternotte S; Combe B; Meyer O; Dougados M
J Rheumatol; 2014 Jan; 41(1):41-6. PubMed ID: 24241481
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
Baecklund E; Backlin C; Rönnelid J; Toes R; Huizinga T; Åhlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
Scand J Rheumatol; 2018 Jul; 47(4):270-275. PubMed ID: 29336646
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis.
Ma L; Wang W; Li L; Chen Y; Chen B; Shao M; Cheng Y; Zhou R
Front Immunol; 2022; 13():940713. PubMed ID: 35983055
[TBL] [Abstract][Full Text] [Related]
15. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study.
Emamifar A; Hangaard J; Jensen Hansen IM
Medicine (Baltimore); 2017 Oct; 96(43):e8357. PubMed ID: 29069018
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the analytical and clinical performances of four anti-cyclic citrullinated peptide antibody assays for diagnosing rheumatoid arthritis.
Cho J; Pyo JY; Fadriquela A; Uh Y; Lee JH
Clin Rheumatol; 2021 Feb; 40(2):565-573. PubMed ID: 32964298
[TBL] [Abstract][Full Text] [Related]
18. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
19. Citrullinated Antigens with Multiple Citrulline Similar Motif in the Diagnosis of Rheumatoid Arthritis: A Preliminary Single-Center Study.
Chen Z; Fang W; Qin Y; Jin YZ; Yang X; Lou J
J Immunol Res; 2021; 2021():1891519. PubMed ID: 34423050
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of magnetic resonance imaging of the hand versus anticyclic citrullinated peptide antibody testing to confirm the diagnosis of clinically suspected early rheumatoid arthritis in the absence of rheumatoid factor and radiographic erosions.
Narváez J; Sirvent E; Narváez JA; Bas J; Gómez-Vaquero C; Reina D; Nolla JM; Valverde J
Semin Arthritis Rheum; 2008 Oct; 38(2):101-9. PubMed ID: 18221987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
